HPV VACCINATION Who should get it, when, and common myths

Cervical cancer remains one of the leading causes of cancer-linked deaths among Indian women, even though it is preventable. In fact, India bears one-fifth of the global cervical cancer burden. This is where the HPV vaccine is so critical, since it protects against the human papillomavirus, the main cause of cervical cancer.

Who should get the HPV vaccine?

The vaccine is best taken early to protect against cervical cancer. The recommended age groups are:

  • Girls and boys aged 9 to 14 years: Two doses, 6 to 12 months apart.
  • Girls/women and boys/men aged 15 to 25 years: Three doses (0, 2, 6 months).
  • Adults aged 27 to 45 years: After consultation with a doctor.

While the ideal vaccination age is 11 to 12 years, catch-up vaccination is recommended for all females through age 26 who are not fully vaccinated.

Common myths vs facts about HPV vaccine

# Myth: Pap smears are also effective, hence vaccination not required.

Fact: The only screening available is for cervical cancer, not other cancers. Five other cancers (affecting both men and women) are caused by HPV. Screening is a secondary prevention method to detect precancerous lesions or cancer early. HPV vaccination is effective in the primary prevention of the disease.

# Myth: HPV vaccines are new and there are no safety and efficacy data on long-term side-effects.

Fact: The possible side-effects are well documented and vaccine safety has been confirmed by WHO and many other authorities.

# Myth: HPV vaccination can cause ovarian failure.

Fact: No connection between HPV vaccination and ovarian failure has been established.

# Myth: Vaccines cause autoimmune diseases, neurological issues and death.

Fact: The incidence of autoimmune or neurological conditions and death is the same in HPV-vaccinated and unvaccinated populations.

# Myth: Children are not sexually active and hence, there’s no need to vaccinate them early.

Fact: The earlier you vaccinate, the better the immune response and strength of prevention. Fewer doses are needed when children are vaccinated under the age of 15 years.

Mucinous Ovarian Neoplasm with Isolated CA 19-9 Elevation

Hello everyone, Today I’m presenting an interesting case of a mucinous ovarian neoplasm with an unusual tumor marker profile. We had a 58-year-old postmenopausal female who presented with progressive abdominal distension and discomfort over a few months. There were no significant gastrointestinal symptoms such as altered bowel habits, bleeding per

Stage IB2 Cervical Carcinoma Managed with Radical Hysterectomy

A 51-year-old postmenopausal woman presented with complaints of intermittent vaginal bleeding and watery discharge for 3 months. There was no significant past medical or surgical history. On per speculum examination, the cervix appeared bulky with an irregular growth. Per vaginal examination revealed a firm cervix with restricted mobility, but no

Advanced Ovarian Cancer Managed with NACT Followed by Interval Debulking Surgery

Case Vlog A 50-year-old woman presented with features suggestive of advanced ovarian malignancy. On evaluation, she was diagnosed with high-grade serous carcinoma (HGSC) of the ovary, with a markedly elevated CA-125 level of 1200. Given the advanced disease burden, the patient was started on neoadjuvant chemotherapy (NACT). She completed planned